1 |
Malueka RG, Nurudhin A, Purwoko P, Sumardi S, Wisaksana R, Adhiputri A, Sudadi S, Soeroto AY, Sidharta BRA, Thobari JA, Murni TW, Soewondo W, Herningtyas EH, Sudjud RW, Trisnawati I, Ananda NR, Faried A, Soetjahjo B. Effectiveness and Safety of Normoxic Allogenic Umbilical Cord Mesenchymal Stem Cells Administered as Adjunctive Treatment in Patients with Severe COVID-19.. [DOI: 10.21203/rs.3.rs-2280239/v1] [Reference Citation Analysis]
|
2 |
Yao W, Dong H, Qi J, Zhang Y, Shi L. Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2022;51:101545. [PMID: 35844767 DOI: 10.1016/j.eclinm.2022.101545] [Reference Citation Analysis]
|
3 |
Charitos IA, Ballini A, Lovero R, Castellaneta F, Colella M, Scacco S, Cantore S, Arrigoni R, Mastrangelo F, Dioguardi M. Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context. Int J Environ Res Public Health 2022;19. [PMID: 36078427 DOI: 10.3390/ijerph191710712] [Reference Citation Analysis]
|
4 |
Chen M, Lai KS, Chien K, Teng ST, Lin Y, Chao W, Lee M, Wei P, Huang Y, Kuo H, Weng C, Chou C. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury. Front Immunol 2022;13:871828. [DOI: 10.3389/fimmu.2022.871828] [Reference Citation Analysis]
|